The US cardiovascular devices market is projected to grow at a significant CAGR of 6.2% during the forecast period. The rising awareness programs for CVD is acting as one prominent factor in the market growth in the US. Moreover, the presence of some of the key players in the US, such as Abbott Laboratories, Boston Scientific Corp., and Edwards Lifesciences Corp., is another factor contributing...